Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
03/2012
03/15/2012WO2011158110A3 Cilostazol cocrystals and compositions
03/15/2012WO2011153348A3 Composition and method for inner ear sensory hair cell regeneration and replacement
03/15/2012WO2011150212A3 Magnetic nanoparticles
03/15/2012WO2011146589A8 Vitamin e conjugates, and their uses as antioxidants and prodrug delivery vehicles
03/15/2012WO2011141791A3 Extended release formulations of desvenlafaxine base
03/15/2012WO2011140446A3 Pharmaceutical formulations
03/15/2012WO2011139348A3 Uses of phospholipid conjugates of synthetic tlr7 agonists
03/15/2012WO2011138197A3 Novel low concentration meloxicam tablets
03/15/2012WO2011138037A3 Solid tapentadol in non-crystalline form
03/15/2012WO2011133635A3 Biodegradable nanoparticles as novel hemoglobin-based oxygen carriers and methods of using the same
03/15/2012WO2011132008A3 Controlled release pharmaceutical composition
03/15/2012WO2011126539A3 Extract of hamelia patens for the treatment of skin disorders
03/15/2012WO2011126294A3 Multi-syringe for producing collagen hydrogel
03/15/2012WO2011124570A3 Oral film formulation
03/15/2012WO2011121289A3 Peptides and their use
03/15/2012WO2011112893A3 Compositions for ameliorating cell proliferative disorders and methods of making and using them
03/15/2012WO2011111962A3 Iontophoresis patch
03/15/2012WO2011104234A3 Multiplication of the efficacy of anti-infectious agents by a composition further comprising a dispersing agent together with a metal activating agent
03/15/2012WO2011101352A3 Test solvent for evaluating the compatibility of biologically active substances and graft copolymers
03/15/2012WO2011088072A3 Dermal delivery device
03/15/2012WO2011086182A3 Pramipexole extended release tablets
03/15/2012WO2011080209A3 Antibody formulation
03/15/2012WO2011078394A3 Sustained-release formulation
03/15/2012WO2011077169A3 Pharmaceutical preparation comprising sufentanil
03/15/2012WO2011076368A3 Topical ophthalmic peptide formulation
03/15/2012WO2011073408A3 Pharmaceutical oral dosage form containing a synthetic oligosaccharide
03/15/2012WO2011069629A3 Pharmaceutical composition comprising oligopeptides, preferably cilengitide
03/15/2012WO2011069037A3 Stabilization and storage of biological pharmaceutical compositions
03/15/2012WO2011060256A3 Bilayer tablet formulations
03/15/2012WO2011026808A8 Oral dosage form, comprising at least one biologically active agent, formulation auxiliary substances and magnetizable particles
03/15/2012WO2002033044A9 Methods of high-throughput screening for internalizing antibodies
03/15/2012US20120066781 Phytases, nucleic acids encoding them and methods for making and using them
03/15/2012US20120065358 Biodegradable poly(beta-amino esters) and uses thereof
03/15/2012US20120065258 Stable prostaglandin-containing compositions
03/15/2012US20120065238 Allantoin-containing skin cream
03/15/2012US20120065180 Androgen pharmaceutical composition and method for treating depression
03/15/2012US20120065175 Method of preparing dry powder inhalation compositions
03/15/2012US20120064299 Hydrogel Implants with Varying Degrees of Crosslinking
03/15/2012US20120064169 Multiple antigen delivery system using hepatitis e virus-like particle
03/15/2012US20120064168 Methods of treatment using a gastric retained gabepentin dosage
03/15/2012US20120064167 Modified-release pharmaceutical drug composition
03/15/2012US20120064166 Formulation comprising drospirenone for subcutaneous or intramuscular administration
03/15/2012US20120064165 Treatment of tissue adhesion
03/15/2012US20120064164 Extended release pharmaceutical compositions
03/15/2012US20120064163 Anti-tumor/cancer heterologous acellular collagenous preparations and uses thereof
03/15/2012US20120064162 Dry-coated orally-disintegrating tablet
03/15/2012US20120064161 Modified release niacin pharmaceutical formulations
03/15/2012US20120064160 Fibrate-statin Combinations with Reduced Fed-fasted Effects
03/15/2012US20120064159 Multilayer Oral Tablets Containing a Non-Steroidal Anti-Inflammatory Drug and/or Acetaminophen
03/15/2012US20120064158 Dissolution properties of drug products containing olmesartan medoxomil
03/15/2012US20120064157 Pharmaceutical composition and administrations thereof
03/15/2012US20120064156 Pharmaceutical Compositions for the Coordinated Delivery of NSAIDs
03/15/2012US20120064155 Oral pharmaceutical composition for use in respiratory diseases
03/15/2012US20120064154 Solid drug for oral use
03/15/2012US20120064153 Compositions and Methods for Treating Centrally Mediated Nausea and Vomiting
03/15/2012US20120064152 Analgesic and Anti-Inflammatory Compositions Comprising Domperidone and Methods of Using Same
03/15/2012US20120064151 Enhanced immune response in avian species
03/15/2012US20120064150 Biocompatible materials containing stable complexes of tsg-6 and hyaluronan and method of using same
03/15/2012US20120064149 High-clarity aqueous concentrates of 4-hexylresorcinol
03/15/2012US20120064148 Ph-responsive liposome
03/15/2012US20120064147 Agent for improving tissue penetration
03/15/2012US20120064146 Wound care device
03/15/2012US20120064144 Method of treating eczema
03/15/2012US20120064143 Inhibition of mammalian target of rapamycin
03/15/2012US20120064142 Polymeric pharmaceutical dosage form in sustained release
03/15/2012US20120064140 Composite nanogranules from polymer/inorganic nanoparticles, preparation method thereof and use of the same
03/15/2012US20120064139 Antimicrobial sucralfate paste methods and compositions
03/15/2012US20120064136 Anti-aging and wrinkle treatment methods using nanoemulsion compositions
03/15/2012US20120064135 Benzoyl Peroxide Composition, Methods for Making Same, and Pharmaceutical or Cosmetic Formulations Comprising Same, and Uses Thereof
03/15/2012US20120064133 Multiparticulate Controlled-Release Selective Serotonin Reuptake Inhibitor Formulations
03/15/2012US20120064132 Antibacterial medical equipment and method for producing the same
03/15/2012US20120064130 Method for impregnation with supercritical co2
03/15/2012US20120064129 Gastric retained gabapentin dosage form
03/15/2012US20120064128 Nano-metallic alloy delivery system for treatment of infected cells and legions
03/15/2012US20120064127 Composition for improving membrane composition and functioning of cells
03/15/2012US20120064126 Dry powder formulations and methods for treating pulmonary diseases
03/15/2012US20120064125 Agr-mediated inhibition of methicillin resistant staphylococcus aureus
03/15/2012US20120064124 Macrolide dosage forms
03/15/2012US20120064123 Composition for a topical ophthalmic clear colloidal liquid which undergoes a liquid-gel phase transition in the eye
03/15/2012US20120064015 Food Additive Composition as an Agent for Reducing the Adhesion of Dental Biofilms in Sweetened Products
03/15/2012US20120064014 Azeotrope-like compositions comprising 1-chloro-3,3,3-trifluoropropene
03/15/2012US20120064013 Foamable topical composition
03/15/2012US20120063997 Delivery system with scaffolds
03/15/2012US20120063996 Novel nimesulide compositions
03/15/2012US20120063994 Rtef-1 variants and uses thereof
03/15/2012US20120063993 Therapeutic and diagnostic conjugates for use with multispecific antibodies
03/15/2012US20120061280 Nutritional supplement composition promoting, increase, development, elevation and activation of "serotonin"
03/15/2012US20120061267 MediTowel Anti-Fungal Wipe
03/15/2012US20120060834 Pharmaceutical preparation to be administered into respiratory organs for treating or preventing inflammatory respiratory diseases, and method for treating or preventing such diseases
03/15/2012DE102010040687A1 Verfahren zum Herstellen von Wirkstoff-Beads A process for producing active ingredient-Beads
03/15/2012CA2810842A1 Macrolide dosage forms
03/15/2012CA2810629A1 Activated leukocyte conditioned supernatant and uses for wound healing
03/15/2012CA2810103A1 Transdermal therapeutic systems with crystallization-inhibiting protective film (release liner)
03/15/2012CA2809927A1 A transdermal drug administration device
03/15/2012CA2809470A1 Oral veterinary preparations
03/15/2012CA2808406A1 Method of mitigating adverse drug events using omega-3 fatty acids as a parenteral therapeutic drug vehicle
03/14/2012EP2428211A2 Pharmaceutical composition for preventing or treating neuronal damage and neurological diseases
03/14/2012EP2428206A1 Thin film with non-self-aggregating uniform heterogeneity and drug delivery systems made therefrom
03/14/2012EP2428205A1 Modified release formulations containing drug-ion exchange resin complexes
03/14/2012EP2428204A2 pH sensitive matrix formulation
1 ... 548 549 550 551 552 553 554 555 556 557 558 559 560 561 562 563 564 565 566 567 568 ... 2991